header logo image

Cellect Biotechnology Gets European Patent (APOP) – Investopedia

April 4th, 2017 10:42 am

Nasdaq
Cellect Biotechnology Gets European Patent (APOP)
Investopedia
secured a European patent covering a method of treatment from the European Patent Office. The patent covers cell-based therapeutics of Cellect's technology and method that have the potential to treat diseases like diabetes, graft-versus-host disease, ...
BRIEF-Cellect Biotechnology receives formal notice of intention to grant for a patent from European patent officeReuters
Cellect Biotechnology (APOP) Granted European Patents Protecting ...StreetInsider.com
Cellect Receives Notice of Intention to Grant from European Patent ...P&T Community

all 9 news articles »

Original post:
Cellect Biotechnology Gets European Patent (APOP) - Investopedia

Related Post

Comments are closed.


2024 © StemCell Therapy is proudly powered by WordPress
Entries (RSS) Comments (RSS) | Violinesth by Patrick